Ignite Creation Date:
2025-12-25 @ 5:05 AM
Ignite Modification Date:
2026-04-23 @ 5:24 AM
Study NCT ID:
NCT02922218
Status:
UNKNOWN
Last Update Posted:
2020-01-27
First Post:
2016-09-29
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
PROSENZA: Prospective Multi-Centre Study of Prognostic Factors in mCRPC Patients Treated With Enzalutamide.
Sponsor:
Centro Nacional de Investigaciones Oncologicas CARLOS III
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-06
Start Date Type:
None
Primary Completion Date:
2020-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2020-12
Completion Date Type:
ESTIMATED
First Submit Date:
2016-09-29
First Submit QC Date:
None
Study First Post Date:
2016-10-04
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-01-23
Last Update Post Date:
2020-01-27
Last Update Post Date Type:
ACTUAL